R. Huennekens

NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA.

Uptake Medical Corp. develops medical technologies for the treatment of lung diseases. It provides InterVapor, an endoscopic lung volume reduction solution for people with severe emphysema that uses the body’s natural healing process without leaving implants or foreign materials in the lung; and InterVapor Personalized Procedure Program, a proprietary application that recommends treatment locations and ablation energy durations for each patient based on the patient’s CT scan. The company was founded by Robert L. Barry in 2004 and is headquartered in Tustin, CA.

Volcano Corp. designs, develops and manufactures a broad suite of intravascular ultrasound products. The company was founded by Olav B. Bergheim and Samuel Ward Casscells and is headquartered in San Diego, CA.

EndoChoice, Inc. operates as a medtech company which focuses on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices, and infection control products and pathology services. Its imaging systems include fuse endoscopy system, fuse accesories, carts, cart options, monitors, monitor cart mounts, monito wall mounts, scope services, and suction pumps and supplies. Its devices include band ligators, biopsy forceps, bipolar probes, bite blocks, cytology brushes, electrosurgical supplies, metal stents, needles, retrieval devices, and snares. The company was founded by Mark G. Gilreath and William Parks in 2007 and is headquartered in Alpharetta, GA.

Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards.

Foldax, Inc. develops synthetic heart valves for delivering non-thrombogenic aortic and mitral valves. The company is headquartered in Salt Lake City, UT.

EndoChoice Holdings, Inc. engages in the development, design and manufacture of medical devices. It offers span single-use devices and infection control products, pathology and imaging systems. The company was founded by Mark G. Gilreath and William Parks in 2008 and is headquartered in Alpharetta, GA.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

Volcano Corp. is a privately held medical device company founded in 2001. With over 400 worldwide employees, Volcano is focused on the discovery, development and commercialization of products for the detection and treatment of atherosclerosis and vulnerable plaques in the coronary and peripheral vascular systems. Volcano products include Intravascular Ultrasound (IVUS) systems and catheters, as well as physiology guide wires. With global distribution, VOLCANO is a leading provider of innovative diagnostic and therapy-guiding technologies to the interventional cardiology and peripheral vascular fields.

REVA Medical, Inc. engages in the development and commercialization of medical devices. It focuses on polymer-based bioresorbable products for vascular applications. The company was founded by Robert Bernard Stockman on June 3, 1998 and is headquartered in San Diego, CA.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

The Medical Device Manufacturers Association operates as a trade association. The private company is based in Washington. The American company was founded by Thomas C. Thompson.

Digma Medical Ltd. develops a device-based, one-time, non-invasive procedure, that restores the body’s natural ability to control glucose, which may provide long term remission from Type-2 Diabetes. The company was founded by Tamir Wolf and Irit Yaniv in 2013 and is headquartered in Petah Tikva, Israel.

Peloton Equity LLC (Peloton Equity) is a private equity firm founded in 2014 by Carlos Ferrer and Ted Lundberg. The firm is headquartered in Greenwich, Connecticut.

Verb Surgical, Inc. designs and manufactures surgical equipment. The company was founded in August 2015 and is headquartered in Santa Clara, CA.

VS, Inc. engages in the development of human-like surgical robotics. It creates virtual reality software for minimally invasive surgery procedures. The company was founded by Adam Sachs, Barry E. Greene and Sammy Khalifa in 2014 and is headquartered in Charlestown, MA.

Hyperfine Research, Inc. provides technology solutions. It designs and develops devices and software to improve healthcare. The company was founded by Jonathan Rothberg and Gregory Charvat in 2014 and is headquartered in Guilford, CT.

Proximie Ltd. is a health technology platform that focuses on digitizing operating and diagnostic rooms. The company is based in London, UK. The British company's mission is to provide quality surgical care globally by delivering a connected surgical platform. Proximie's platform allows for every procedure to be recorded, analyzed, and leveraged for future use to inform best practices. Proximie's ultimate ambition is to create a future network of operating rooms interconnected by the world's best clinicians, where every incision is already informed by machine learning and every clinician will be empowered with real-time diagnostics, data, and analysis. The company was founded in 2016 by Dr. Nadine Hachach-Haram and Talal Ali Ahmad. Dr. Nadine Hachach-Haram has been the CEO since 2016.

Kardion GmbH is a German company that manufactures and supplies medical technical instruments. The company is based in Stuttgart, Germany. The CEOs of the company are Hardy Baumbach, Inga Schellenberg.

Q'Apel Medical, Inc. designs novel access device technology for vascular interventions and unmet clinical needs. The company is based in Fremont, CA. The CEO of the company is R. King Nelson.

VIDA FLaSH Acquisitions operates as a development stage company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Frank Litvack and Scott R. Huennekens on January 29, 2021 and is headquartered in Los Angeles, CA.

Reachora Ltd., through its platform wondr medical, aims to accelerate medical learning and discovery by creating the world's most connected medical network. The company is based in London, UK. The platform is built around healthcare professionals who are driven by curiosity to discover more, from breakthrough research to advances in best practice, and from meeting collaborators to learning from mentors and peers. Wondr medical helps doctors and medical professionals across the world collaborate, connect, and discover medical information. The British company was founded in 2016 by Justin Edgar Rees Davies, who has been the CEO since 2016.